Ross Hamilton

Background

About Ross Hamilton

Managing our nonclinical development and label expansion programs with the goal of advancing our drugs to the clinic and expand their applications to other relevant indications; thus, significantly increasing company valuation. Strong experience (13+ years) across multiple indications (liquid/solid cancers, autoimmune, fibrosis, immuno-oncology, neurological, and others) and with advancing diverse therapeutic modalities (biologics, small molecules, oligonucleotide therapeutics, and radiopharmaceuticals) – each having unique needs and regulatory requirements for approval. Acquired deep expertise in business development, raising private equity/finance, successfully sourcing non-dilutive funding, establishing collaborations, managing intellectual property, and regulatory compliance. Demonstrated aptitude for leading teams, rapidly learning new concepts, and mentoring others. During Ph.D. program, gained extensive scientific (methodology), leadership, management, and strategy experience under the mentorship of Dr. Bert W. O’Malley, National Medal of Science awardee (2008). Career interests include bio-entrepreneurship, life science consulting, company creation, and drug development.